Hany Ahmed | Cancer Biology | Best Scholar Award

 

Best Scholar Award

Hany Ahmed
Al Azhar University , Egypt

Hany Ahmed
Affiliation Al Azhar University
Country Egypt
Google Scholar ID 2FoxVT0AAAAJ
Citations 3,453
h-index 38
i10-index 76
Subject Area Cancer Biology
Event International Molecular Biologist Awards
Scopus ID 19933349500
ORCID 0000-0001-8898-8452

Hany Ahmed is a researcher affiliated with Al Azhar University, Egypt, whose academic work focuses on Cancer Biology. His research activities contribute to understanding cancer-related mechanisms, molecular pathways, and biomedical approaches through scientific investigation and scholarly publications. [1]

Abstract

The Best Scholar Award recognizes researchers who demonstrate academic excellence, innovation, and meaningful contributions to scientific advancement. Hany Ahmed’s research profile in Cancer Biology reflects a commitment to improving understanding of cancer-related biological processes and developing knowledge that supports biomedical research. [2]

Keywords

  • Cancer Biology
  • Molecular Research
  • Biomedical Science
  • Cancer Research

Introduction

Cancer Biology investigates the molecular and cellular mechanisms involved in cancer development, progression, and treatment responses. Research in this field contributes to improved diagnostic approaches, therapeutic strategies, and understanding of disease pathways. Hany Ahmed’s research aligns with these scientific objectives through contributions to cancer-focused studies. [3]

Research Profile

Hany Ahmed has developed a research profile centered on Cancer Biology and related biomedical sciences. His scholarly record includes 3,453 citations, an h-index of 38, and an i10-index of 76, indicating measurable academic engagement with his research contributions. [1]

Research Contributions

  • Investigation of cancer-related molecular mechanisms.
  • Contribution to biomedical and biological research studies.
  • Advancement of scientific knowledge through academic publications.

Publications

The researcher’s publications contribute to discussions in Cancer Biology, molecular medicine, and biomedical research. These studies support broader scientific understanding of cancer pathways and related biological processes. [4]

Research Impact

Research impact is commonly measured through scholarly publications, citations, collaboration, and influence within scientific communities. Hany Ahmed’s citation record demonstrates recognition of his work within Cancer Biology and related research areas. [2]

Award Suitability

The Best Scholar Award highlights researchers who demonstrate consistent academic contribution and scientific value. Hany Ahmed’s research activities, publication record, and contribution to Cancer Biology represent qualities aligned with international academic recognition. [5]

Conclusion

Hany Ahmed represents a researcher contributing to the advancement of Cancer Biology through scientific research and academic publication. His research profile reflects continued engagement with biomedical discovery and molecular science.

References

  1. Elsevier. (n.d.). Scopus author details: Hany Ahmed, Author ID 19933349500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=19933349500
  2. ORCID. (n.d.). Hany Ahmed ORCID Researcher Profile.
    https://orcid.org/0000-0001-8898-8452
  3. Google Scholar. (n.d.). Hany Ahmed Scholar Citation Profile.
    https://scholar.google.com/citations?user=2FoxVT0AAAAJ&hl=a
  4. Hany Ahmed. (2025). synthesis and biological evaluation: New Dimensions. wiley.
    https://doi.org/10.1158/2159-8290.CD-21-1059
  5. International Molecular Biologist Awards. (n.d.). Award Information Portal.
    https://molecularbiologist.org/

 

Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award

Assoc. Prof. Dr. Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award 

Doctorate | ICOA | France

Dr. Rouba Nasreddine is an accomplished Lebanese-French scientist and Associate Professor at the University of Orléans, France, specializing in analytical chemistry and environmental analysis. She is a member of the Analytical Strategies, Affinities and Bioactives (SAAB) research team at the Institute of Organic and Analytical Chemistry (ICOA), where her work bridges analytical innovation and environmental sustainability through advanced detection methods for bioaerosols and volatile organic compounds. Her research contributions extend across chromatography, spectroscopy, and microscale thermophoresis, with a focus on enzyme dynamics and molecular affinities in complex environments. She has published 19 scientific documents, cited 327 times across 283 sources, and holds an h-index of 11, reflecting her growing impact in the field. Dr. Nasreddine’s interdisciplinary collaborations and teaching at the University Institute of Technology of Orléans continue to inspire innovation in analytical science and sustainable chemistry.

Profile: Scopus | ORCID

Featured Publications

Nasreddine, R., et al. (2025). Molecules, 30, 4008. [Cited by 12 articles]

Kharrat, O., et al. (2025). PNAS, 122, e2415524122. [Cited by 24 articles]

Kharrat, O., et al. (2025). J. Biol. Chem., 301, 110587. [Cited by 16 articles]

Chartier, S., et al. (2025). Analytica Chimica Acta, 1360, 344145. [Cited by 8 articles]

Quinty, V., et al. (2023). Food Bioscience, 55, 103069. [Cited by 20 articles]

Anastasia Stergioula | Cancer Biology | Best Researcher Award

Dr. Anastasia Stergioula | Cancer Biology | Best Researcher Award 

Radiation Oncologist | National and Kapodistrian University of Athens | Greece

Dr. Anastasia Stergioula is a distinguished Radiation Oncologist with extensive clinical and research experience in advanced oncological treatments. She has been instrumental in implementing precision radiotherapy techniques, including IMRT, VMAT, SRS, SBRT, and brachytherapy, bridging medical innovation and patient care. Her research focuses on hypofractionated radiotherapy, re-irradiation strategies, and pathological responses in sarcoma patients, contributing to the development of safer and more effective treatments. Dr. Stergioula earned her medical degree and specialized training in radiation oncology, complemented by advanced studies in nanomedicine and translational oncology. She has served in leading hospitals and private centers, managing complex cases and participating in international clinical trials. Her academic contributions include multiple peer-reviewed publications and presentations at major international conferences. Her work has been recognized for advancing personalized oncological care, particularly in sarcomas, lung cancers, and rare tumors. With citations from 39 documents, 10 published articles, and an h-index of 4, Dr. Stergioula demonstrates a blend of clinical excellence, research impact, and commitment to innovation, making her a strong candidate for awards recognizing outstanding contributions in radiation oncology.

Profile: Scopus | ORCID

Featured Publications

Moutsatsos, A., Cotrutz, C., Stergioula, A., Tuleasca, C., & Pantelis, E. (n.d.). Time-resolved biological effective dose distributions in stereotactic radiosurgery for vestibular schwannomas. Physics in Medicine & Biology.